Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Intangibles (2017 - 2025)

Dr Reddys Laboratories (RDY) has 7 years of Intangibles data on record, last reported at $375.3 million in Q1 2023.

  • For Q1 2023, Intangibles rose 3.57% year-over-year to $375.3 million; the TTM value through Mar 2023 reached $375.3 million, up 3.57%, while the annual FY2023 figure was $384.5 million, 5.12% up from the prior year.
  • Intangibles reached $375.3 million in Q1 2023 per RDY's latest filing, up from $362.3 million in the prior quarter.
  • Across five years, Intangibles topped out at $628.9 million in Q1 2019 and bottomed at $362.3 million in Q1 2022.
  • Average Intangibles over 5 years is $447.4 million, with a median of $381.8 million recorded in 2020.
  • Peak YoY movement for Intangibles: crashed 39.29% in 2020, then increased 28.06% in 2021.
  • A 5-year view of Intangibles shows it stood at $628.9 million in 2019, then plummeted by 39.29% to $381.8 million in 2020, then increased by 28.06% to $488.9 million in 2021, then decreased by 25.89% to $362.3 million in 2022, then rose by 3.57% to $375.3 million in 2023.
  • Per Business Quant database, its latest 3 readings for Intangibles were $375.3 million in Q1 2023, $362.3 million in Q1 2022, and $488.9 million in Q1 2021.